Corbion reports strong Q3 2026 results, halts PLA sale, reaffirms guidance

Corbion reported Q3 2026 results with strong organic sales growth across its Functional Ingredients & Solutions and Health & Nutrition segments. Management halted the sale of its PLA business, saying received proposals undervalued the asset, and reaffirmed full-year 2026 guidance supported by a visible Q4 order book.

Detected & updated continuously · Source: Nebula